References
- Oba MS, Murakami Y, Nishiwaki Y, et al. Estimated prevalence of Cronkhite-Canada syndrome, chronic enteropathy associated with SLCO2A1 gene, and intestinal Behçet's Disease in Japan in 2017: a Nationwide Survey. J Epidemiol. 2021;31(2):139–144.
- Sweetser S, Alexander GL, Boardman LA. A case of Cronkhite-Canada syndrome presenting with adenomatous and inflammatory Colon polyps. Nat Rev Gastroenterol Hepatol. 2010;7(8):460–464.
- Cronkhite L W JR, Canada WJ. Generalized gastrointestinal polyposis; an unusual syndrome of polyposis, pigmentation, alopecia and onychotrophia. N Engl J Med. 1955;252(24):1011–1015.
- Goto A. Cronkhite-Canada syndrome: epidemiological study of 110 cases reported in Japan. Nihon Geka Hokan. 1995;64(1):3–14.
- Watanabe C, Komoto S, Tomita K, et al. Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite-Canada syndrome: a japanese nationwide survey. J Gastroenterol. 2016;51(4):327–336.
- Lu Y, Huang F, Wang Y, et al. Clinical and endoscopic characteristics of Chinese Cronkhite-Canada syndrome patients: a retrospective study of 103 cases. Dig Dis. 2021;39(5):488–495.
- Goto A, Mimoto H, Shibuya C, et al. Cronkhite-Canada syndrome: an analysis of clinical features and follow-up studies of 80 cases reported in Japan. Nihon Geka Hokan. 1988;57(6):506–526.
- Fan RY, Wang XW, Xue LJ, et al. Cronkhite-Canada syndrome polyps infiltrated with IgG4-positive plasma cells. World J Clin Cases. 2016;4(8):248–252.
- Boland BS, Bagi P, Valasek MA, et al. Cronkhite Canada syndrome: significant response to infliximab and a possible clue to pathogenesis. Am J Gastroenterol. 2016;111(5):746–748.
- Nagata J, Kijima H, Hasumi K, et al. Adenocarcinoma and multiple adenomas of the large intestine, associated with Cronkhite-Canada syndrome. Dig Liver Dis. 2003;35(6):434–438.
- Padda MS, Ryu J, Pham BV. Unusual cause of diarrhea: cronkhite-Canada syndrome. Clin Gastroenterol Hepatol. 2008;6(6):A28.
- Kopacova M, Urban O, Cyrany J, et al. Cronkhite-Canada syndrome: review of the literature. Gastroenterol Res Pract. 2013;2013:856873.
- Takeuchi Y, Yoshikawa M, Tsukamoto N, et al. Cronkhite-Canada syndrome with Colon cancer, portal thrombosis, high titer of antinuclear antibodies, and membranous glomerulonephritis. J Gastroenterol. 2003;38(8):791–795.
- Wen XH, Wang L, Wang YX, et al. Cronkhite-Canada syndrome: report of six cases and review of literature. World J Gastroenterol. 2014;20(23):7518–7522.
- Li Y, Luo HQ, Wu D, et al. [Clinicopathologic features of Cronkhite-Canada syndrome and the significance of IgG4-positive plasma cells infiltration]. Zhonghua Bing Li Xue Za Zhi. 2018; 47(10):753–757.
- Yamakawa K, Yoshino T, Watanabe K, et al. Effectiveness of cyclosporine as a treatment for steroid-resistant Cronkhite-Canada syndrome; two case reports. BMC Gastroenterol. 2016;16(1):123.
- Schulte S, Kutting F, Mertens J, et al. Case report of patient with a Cronkhite-Canada syndrome: sustained remission after treatment with corticosteroids and mesalazine. BMC Gastroenterol. 2019;19(1):36.
- Cho W, Nam K, Bang KB, et al. Cronkhite-Canada syndrome showing good early response to steroid treatment. Korean J Gastroenterol. 2018;71(4):239–243.
- Sweetser S, Ahlquist DA, Osborn NK, et al. Clinicopathologic features and treatment outcomes in Cronkhite-Canada syndrome: support for autoimmunity. Dig Dis Sci. 2012;57(2):496–502.
- Wu ZY, Sang LX, Chang B. Cronkhite-Canada syndrome: from clinical features to treatment. Gastroenterol Rep (Oxf)). 2020;8(5):333–342.
- Okamoto K, Isomoto H, Shikuwa S, et al. A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimen. Digestion. 2008;78(2-3):82–87.
- Kato K, Ishii Y, Mazaki T, et al. Spontaneous regression of polyposis following abdominal colectomy and Helicobacter pylori eradication for Cronkhite-Canada syndrome. Case Rep Gastroenterol. 2013;7(1):140–146.
- Ong S, Rodriguez-Garcia C, Grabczynska S, et al. Alopecia areata incognita in Cronkhite-Canada syndrome. Br J Dermatol. 2017;177(2):531–534.
- Chuamanochan M, Tovanabutra N, Mahanupab P, et al. Nail matrix pathology in Cronkhite-Canada syndrome: the first case report. Am J Dermatopathol. 2017;39(11):860–862.
- Maaser C, Sturm A, Vavricka SR, European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR], et al. ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13(2):144–164.
- Gupta A, Postgate AJ, Burling D, et al. A prospective study of MR enterography versus capsule endoscopy for the surveillance of adult patients with Peutz-Jeghers syndrome. AJR Am J Roentgenol. 2010;195(1):108–116.
- Amzallag-Bellenger E, Oudjit A, Ruiz A, et al. Effectiveness of MR enterography for the assessment of small-bowel diseases beyond crohn disease. Radiographics. 2012;32(5):1423–1444.
- Ward E, Wolfsen HC, Ng C. Medical management of Cronkhite-Canada syndrome. South Med J. 2002;95(2):272–274.
- Taylor SA, Kelly J, Loomes DE. Cronkhite-Canada syndrome: sustained clinical response with anti-TNF therapy. Case Rep Med. 2018;2018:9409732.